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CLINICAL UPDATE
Enteric fever
Buddha Basnyat, 1 , 2 Farah Naz Qamar, 3 Priscilla Rupali, 4 Tahmeed Ahmed, 5 Christopher M Parry2 , 6
What you need to know
• In endemic areas and in returning travellers, consider
enteric fever in the differential diagnosis in patients
with acute fever, particularly if they have abdominal
symptoms
• Routine blood tests and blood culture can aid the
diagnosis; serological tests, including the Widal test,
are not recommended
• Antimicrobial resistance is common, so refer to
national guidelines or formularies for choice of
antibiotic
• In endemic areas, rule out other causes of acute fever
such as malaria and dengue with tests and consider
adding empirical treatment with doxycycline (or
azithromycin) for scrub typhus and leptospirosis
• The Vi polysaccharide vaccine and Ty21a vaccine are
available for use in travellers. The typhoid Vi
conjugate vaccine is now recommended by the WHO
in endemic areas
Enteric fever, also known as typhoid fever, is a
common infectiousdisease in lowandmiddle income
countries.1 It is the commonest bacterial cause of
fever in returning travellers and migrants from these
areas.23 About 14millionpeople are affectedannually
with 136 000 deaths, mainly in low and middle
income countries, according to estimates from the
Global Burden of Disease Study in 2017.1
Diagnosis is complicated as symptoms overlap with
other causes of fever and early investigations are
inconclusive. Antimicrobial resistance is a growing
concern. General practitioners have an important
role in early diagnosis and management, prompt
referral of patients with severe disease, and
prevention including vaccination.
How is it caused?
Enteric fever encompasses typhoid fever, caused by
infection with bacteria Salmonella Typhi (S Typhi),
and paratyphoid fever, caused by Salmonella
Paratyphi A and B. S Typhi is estimated to cause 76%
of enteric fever globally.1 Paratyphoid fever ismostly
seen in parts of South Asia and China.1 4 Ingestion of
foodorwater contaminatedby infectedhuman faeces
causes infection.5
Who gets enteric fever?
Poor access to clean drinking water and inadequate
sanitation and hygiene increase the risk of
transmission.5 6 Enteric fever is most common in
South Asia (incidence >500 per 100 000 population);
South-East Asia, sub-Saharan Africa, and Oceania
(>100 per 100 000 population); and Latin America
and Caribbean (1-10 per 100 000 population).1 7
Children and young adults are more commonly
affected.8 -10 Among travellers, enteric fever is more
common in adults after a visit to endemic areas.2 3
Useofprotonpump inhibitors increases susceptibility
to enteric fever by reducing gastric acidity, as per a
systematic review.11 The role of HIV infection as a
risk factor is unclear, but itmay contribute to disease
severity.12 A case series reported neonatal sepsis due
to S Typhi and Paratyphi in babies born to infected
mothers.13
How do patients present?
Patients present with a gradual onset of fever which
typically rises to a plateau of 39-40°C (102-104°F)
towards the end of a week.8 -10 This slow rise in fever
contrasts with the intermittent high fever and rigors
seen in malaria.
Abdominal symptoms such as diarrhoea, nausea,
vomiting, and abdominal pain are common as per a
systematic review on clinical profile of enteric fever
(see supplementary table 1 onbmj.com).9 Abdominal
pain is diffuse and poorly localised but occasionally
intense in the right iliac fossa, mimicking
appendicitis. Patients may also have headache,
cough, and malaise. Children under 5 years old
frequently presentwith only fever, and thediagnosis
may be missed unless they have complications.9
Symptoms start 7-14 days after exposure (range 3-60
days). Paratyphoid fever has a shorter incubation
period (4-5days), but symptomsare indistinguishable
from those of typhoid fever.4 14
How is it diagnosed?
Enteric fever is mainly a clinical diagnosis based on
history and examination. A gradual onset of fever,
particularly with one or more abdominal symptoms,
should raise suspicion of enteric fever in endemic
areas. Ask about travel to endemic regions.
Physical findings are often non-specific.8 -10 Soft
tender hepatosplenomegaly, abdominal distension,
mild ascites, and a diffuse or localised tenderness
maybenoticed onabdominal examination.Hepatitis
and hepatomegaly are more common in children
under 5 years old and are seen in 30-50% of children
with enteric fever.9 Scattered wheezes or crepitations
in the chest might suggest bronchitis. A bradycardia
relative to the height of the fever may be noted. Rose
spots, blanching erythematous maculopapular
lesions on the trunk, were considered characteristic
of typhoid fever, but are now rarely reported (fig 1).9
If the disease progresses beyond the first week the
patient oftenbecomes impassive andunresponsive.10
1the bmj | BMJ 2021;372:n437 | doi: 10.1136/bmj.n437
PRACTICE
OPEN ACCESS
1 Oxford University Clinical Research
Unit-Patan Academy of Health
Science Kathmandu, Nepal
2 Centre for Tropical Medicine and
Global Health, University of Oxford,
Oxford, UK
3 Aga Khan University, Karachi,
Pakistan
4 Christian Medical College, Vellore,
India
5 icddr,b, Dacca, Bangladesh
6 Alder Hey Children’ Hospital and
Liverpool University Hospitals.
Liverpool, UK
Correspondence to: B Basnyat
Buddha.Basnyat@ndm.ox.ac.uk
Cite this as: BMJ 2021;372:n437
http://dx.doi.org/10.1136/bmj.n437
Published: 26 February 2021
 on 19 M













J: first published as 10.1136/bm





Fig 1 | Example of erythematous maculopapular lesions on the trunk characteristic of typhoid fever
What are the investigations?
Request a complete blood count and blood culture. The total white
cell count is usually within, or just below, the normal range in
enteric fever. Leucocytosis (raised white cell count) may suggest
intestinal perforation or another diagnosis such as a pyogenic
infection or leptospirosis. A mild normochromic or hypochromic
anaemia, mild thrombocytopenia, and mild elevation of liver
transaminases with a normal bilirubin are common.8 -10 The C
reactive protein (CRP) is usually elevated in enteric fever.
Blood culture is the optimum method to confirm the diagnosis by
isolating the organism and testing antimicrobial sensitivity. It takes
two to three days for a result, and empirical antimicrobial treatment
is required in the interim. It has a sensitivity of 61% (95% CI 52 to
70) (see supplementary table 2 on bmj.com).15 16 A negative blood
culture does not exclude enteric fever. Antibiotic pre-treatment,
low sample volume, and low circulating bacterial load in the blood
result in this low sensitivity.16 17 Bone marrow culture gives a higher
yield, but it is rarely performed.17 Faeces, urine, or bile aspirate may
be cultured, but apositive resultmay indicate chronic faecal carriage
rather than acute infection.10
Serological tests, including the Widal test and newer rapid
diagnostic tests, are not confirmatory in the acute phase of illness.
The Widal test measures antibodies against O and H antigens of S
Typhi and SParatyphi A. It is cheap and simple but lacks sensitivity
and specificity.18 19 A single measurement in the acute phase of the
illness may be false negative or false positive.10 19 Other
commercially available, point-of-care rapid diagnostic tests detect
IgM antibodies against S Typhi antigens. These are insufficiently
accurate to be useful in diagnosis (see supplementary table 2).20 In
a diagnostic accuracy review, the TUBEX test (14 studies) had an
average sensitivity of 78% (95% CI 71% to 85%) and specificity of
87% (82% to 91%). The Typhidot test had an average sensitivity of
66% (59% to 73%) with a specificity of 81% (58% to 93%)20 across
a number of versions. Novel assays to detect antibodies, antigens,
and DNA in blood are being developed.21 22
In endemic areas and returning travellers, rule out malaria and
dengue fever with testing. Consider other causes of acute fever
based on local disease patterns—such as scrub and murine typhus,
leptospirosis, brucellosis, influenza, chikungunya, and covid-19
and other viral conditions.3 21 23
What are the complications?
Severe disease usually manifests in the second or third week of
illnesswith continuing fever, increasingweakness, anaemia,weight
loss, persistent vomiting, or a clouded mental state. Delayed
treatment, the virulence of the bacterial strain, and host factors
contribute to disease severity.24 In a pooled analysis (13 studies,
2554 patients), 27% (95% CI 21% to 32%) of patients with enteric
fever experiencedcomplications.24Encephalopathy, gastrointestinal
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bleeding, nephritis, and hepatitis are common complications seen
in 5-7% of hospitalised patients24 (see supplementary table 3).
Intestinal haemorrhage or colitis and intestinal perforation can
occur. These present with signs of acute peritonitis or more
insidiouslywith increasing restlessness, adiffusely tender abdomen,
hypotension, tachycardia, and shock.24 -26
Themean case fatality ratewith enteric fever is 2.49% (95%CI 1.65%
to 3.75%), and 4.45% (2.85% to 6.88%) in hospitalised patients as
per a recent systematic review (44 studies, 41 723 patients).27
Between 5% and 10% of patients experience a relapse with a second
episodeof fever two to threeweeks after initial recovery. This usually
responds to the original treatment.10
How is it treated?
Initial treatment and referral
Patients can usually be managed at home if they have no
complications. Referral to a hospital is necessary if the patient is
vomiting and unable to take oral medication, is clinically unstable
(see box for “red flags”), has developed complications, or if the
diagnosis is uncertain.
Red flags for referral of patients
Adults
• Two or more of the following the Quick Sepsis-related Organ Failure
Assessment (qSOFA) criteria on initial examination:
‐ Altered mental status
‐ Respiratory rate ≥22 breaths/min
‐ Systolic blood pressure ≤100 mm Hg
• The patient may be at risk of severe sepsis and needs higher level of
care
Children
• Looking sick and toxic
• Unable to take oral medication
• Persistent vomiting
• Signs of severe dehydration
• Abdominal distension with or without tenderness
• Jaundice
• Drowsy or altered consciousness
• Signs of gastrointestinal bleeding (such as passing fresh blood in
stools or melaena)
• Signs of haemodynamic shock, including mottled skin and reduced
capillary return
• Seizures
• Any sign of severe disease as per the Integrated Management of
Childhood Illness Algorithm (IMCI)47
Effective antimicrobial therapy shortens the illness and reduces
mortality from complications.10 As there is no simple confirmatory
test for enteric fever, empirical treatment is advised in endemic
areas at the time of presentation. Oral antimicrobials may be started
inpatientswith fever for three to four days and suggestive symptoms
with no apparent focus of infection identified and, where relevant,
a negative malaria smear. Although such empirical use may lead
to antimicrobial overuse, the absence of a simple diagnostic test
leaves no alternative.
Ensure adequate hydration, antipyretics for fever, and careful
follow-up.10Concurrent treatmentwithdoxycycline (or azithromycin
in children) is advised to cover for scrub typhus and leptospirosis
where these infections are endemic.23 28 High dose corticosteroids
may be considered in patients with severe disease or complications
(see table 1).32
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* Culture and susceptibility results often unavailable. Empirical treatment should be based on regional knowledge of susceptibility patterns.
†Ofloxacin and levofloxacin are effective alternatives.
‡Chloramphenicol may cause bone marrow suppression; oral route preferred.
§ TMP-SMX = trimethoprim-sulphamethoxazole. Inexpensive; may cause allergic reactions and nephrotoxicity, not suitable for children <2 years old or during pregnancy.
¶ 8 mg/kg trimethoprim–40 mg/kg sulphamethoxazole.
**Multidrug resistant: resistant to chloramphenicol, amoxycillin, trimethoprim-sulphamethoxazole
††Quinolone resistant: non-susceptible to ciprofloxacin (pefloxacin resistant/ciprofloxacin resistant by disk testing)
‡‡ Extensively drug resistant: resistant to chloramphenicol, amoxycillin, trimethoprim-sulphamethoxazole, ciprofloxacin, and ceftriaxone
§§ In severe enteric fever (characterised by delirium, obtundation, coma, or shock) dexamethasone may be beneficial (dose 3 mg/kg infused intravenously over 30 min, followed by 8 doses of 1 mg/kg every 6 hours). In
severe enteric fever with intestinal perforation and peritonitis, a laparotomy is recommended to identify and close the perforation(s) and to perform cleaning of the peritoneal cavity.
Choice of antimicrobial
Antimicrobial choice (table 1) is complicated by resistance to
commonly used drugs. Culture and susceptibility results are crucial
to guide treatment for individual patients and to monitor regional
resistance rates, but these are often unavailable in endemic areas
because of the lack of microbiology capacity. Consult national
guidelines or local formularies for choice of antimicrobial based on
regional susceptibility patterns.28 33
Chloramphenicol, amoxicillin, and
trimethoprim-sulphamethoxazole were first-line choices before the
1990s. Multidrug resistance, defined as resistance to these three
antimicrobials, led to use of fluoroquinolones (ciprofloxacin,
ofloxacin, levofloxacin) for enteric fever.33 High rates of
fluoroquinolone resistance are now reported in South Asia and
increasingly in Africa.33 34 Extended spectrum cephalosporins, oral
cefixime and parenteral ceftriaxone, and oral azithromycin28 -31 33
are now recommended options. Cefixime and ceftriaxone are
associatedwithhigher rates of relapse. Resistance to all three agents
is appearing.3536 Since a large outbreak of extensively drug resistant
typhoid (resistant to ciprofloxacin, ceftriaxone, amoxycillin,
chloramphenicol, and trimethoprim-sulphamethoxazole) inPakistan
in 2016, the treatment choice for such infections has shifted to oral
azithromycin or parenteral meropenem.37 38
Follow-up
Fever resolves in five to 10 days, but patients often feel better sooner
as fever intervals and intensity improve. Antibiotic treatment
durations of 7-14 days or five days after fever resolution, whichever
is longer, have traditionally been used. In clinical trials, shorter
durations of between three and five days of ceftriaxone and
ofloxacin have proved effective in uncomplicated
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disease.29 30Patients commenced on parenteral antimicrobials can
be switched to oral medications once they are clinically stable. If
the susceptibility pattern is known, de-escalate from a broad
spectrum to a narrow spectrum drug.
Re-evaluate patients with persistent high fever and symptoms after
7-10 days of treatment. Blood culture can be repeated to detect
antimicrobial resistance or another diagnosis.
What about chronic carriage?
Carriers are asymptomatic but can transmit infection. About 10%
of patients who have had an episode of enteric fever intermittently
shed bacteria in faeces for several weeks after infection.39 If
shedding continues beyondone year, it is called chronic carriage.539
The focus of infection in chronic carriage is thought to be the gall
bladder, and carriage is more common in individuals with gall
bladder disease and in women over 40 years old.39 There is an
increased risk of cholecystitis and carcinoma of the gallbladder in
chronic carriers. A meta-analysis reported an odds ratio of of 4.28
for gall bladder malignancy in S Typhi carriers.40 Kidney stones, as
well as schistosomal infection in African studies, increase the risk
of persistent typhoid urinary tract infection and chronic urinary
carriage.41
Public health authorities, such as Public Health England,
recommend three negative faecal culture samples a minimum of
48 hours apart after an acute episode of enteric fever to exclude
carriage.42 This is particularly important in food handlers and staff
working in healthcare or day care facilities. An elevated Vi antibody
titre (antibody to the Vi antigen of S Typhi) is helpful in detecting
carriers in low incidence settings but not in endemic areas or areas
with widespread use of vaccine. Eradication requires prolonged
treatment with high dose antibiotics (table 1), and, rarely,
cholecystectomy to surgically remove the focus of infection.10
How can enteric fever be prevented?
Improving access to clean drinking water, hygienic sanitation, and
safe sewage disposal is critical to reduce the burden of disease in
endemic areas. There is a need for high food hygiene standards and
for prompt management of acute illness and chronic carriers.5 For
travellers, regular hand washing; using bottled water; avoiding
contaminated water, salads, ice, and street food; and pre-travel
vaccination can prevent infection.
Typhoid vaccination can potentially reduce disease burden among
infants, children, young adults, and professional food handlers in
endemic areas. The World Health Organization has approved three
typhoid vaccines. These are not yet part of routine immunisation
programmes in countries. There are no paratyphoid fever vaccines.
Ty21a is a live attenuated oral vaccine. A three-dose schedule has
a cumulative efficacy at 2.5-3 years of 50% (95% CI 35% to 61%, 4
trials, 235 239 participants aged 3-44 years; moderate certainty
evidence). Fever was more common following Ty21a vaccination
compared with placebo. The Vi capsular polysacchride vaccine
(ViPS) is given as a single injection and has an efficacy of 59% (45%
to 69%; 4 trials, 194 969 participants aged 2-55 years; moderate
certainty evidence) after two years.43 Re-vaccination is
recommended after three years with both these vaccines. Swelling
and pain at the injection site were more common in the vaccine
group. Both these vaccines are of limited value inpreschool children
because of difficulties of administration (Ty21a oral capsules) or
inferior immune response (ViPS).
In 2018 theWHOrecommendedanew typhoidVi conjugate vaccine
(TCV) for use in children above 6 months of age.44 45 The vaccine
has Vi polysaccharide antigen conjugated to tetanus toxoid (Vi-TT)
and is given as a single injection. It had an efficacy of 81.6% (58.8%
to 91.8%) in a randomised controlled trial (20 0019 participants) in
Nepal.44 Low but similar rates of adverse events such as local pain,
swelling, redness, or fever were noted in the two trial groups. The
need for booster injectionswith TCV is unresolved. In 2018, Pakistan
recently used the TCV vaccine in children aged 9 months to 15 years
in an effort to control the outbreak of extensively drug resistant
typhoid in Sindh province.46 Further trials of this and other typhoid
conjugate vaccines are in progress.
Sources and selection criteria
We searched PubMed, Embase, and the Cochrane Library for studies
published in English between January 1990 and May 2020 using the
MeSH terms: “(epidemiology, diagnosis, treatment, guideline) and (enteric
fever, typhoid fever, paratyphoid fever).” Key references identified in
review articles and textbooks and from the authors own collections were
hand searched. We focused our selection on relevant papers published
between January 2017 and June 2020. We also examined relevant reports
from the World Health Organization.
Questions for future research
• What are reliable rapid diagnostic tests for undifferentiated febrile
illness, including enteric fever, in low and middle income countries?
• What is the optimal antimicrobial therapy for antimicrobial-resistant
enteric fever including extensively drug resistant typhoid?
• What antimicrobial combinations are effective for treatment of enteric
fever, and how do they compare with monotherapy?
• What is the cost effectiveness of including typhoid vaccines in the
routine immunisation programme in countries with high burden of
enteric fever?
How patients were involved in the creation of this article
We asked a patient with enteric fever to share her story. She was initially
diagnosed as having a viral fever. When high fever persisted, she returned
to the clinic. She was suspected to have typhoid fever, and lab
investigations were done. She was started on antibiotics, and her fever
improved in a few days. Her blood culture came out to be negative. Her
experience highlights the challenges with diagnosis of enteric fever. We
have attempted to reflect on these in the article. We are grateful for the
patient’s input.
Additional educational resources
• European Centre for Disease Prevention and Control. Typhoid and
paratyphoid fever. https://www.ecdc.europa.eu/en/typhoid-and-
paratyphoid-fever
‐ Includes a toolkit for outbreak response to food and waterborne
diseases
• Indian Council of Medical Research. ICMR guidelines on management
of acute fever. https://speciality.medicaldialogues.in/icmr-guidelines-
on-management-of-acute-fever
‐ Useful for treatment of acute febrile illness, of which enteric fever
is the commonest bacterial cause in South Asia
• Medical Microbiology and Infectious Diseases Society of Pakistan.
Typhoid management guidelines 2019. https://www.mmidsp.com/ty-
phoid-management-guidelines-2019/
‐ Useful guideline from an area with extensively drug resistant
typhoid
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Information resources for patients
• Centers for Disease Control and Prevention. Typhoid fever and
paratyphoid fever. https://www.cdc.gov/typhoid-fever/resources.html
‐ Free website with information for travellers and local language
factsheets for patients (including Hindi, Bengali, and Urdu)
• Coalition against Typhoid and Typhoid Vaccine Acceleration
Consortium. Take on typhoid. https://www.coalitionagainstty-
phoid.org/
‐ Free website with blogs and stories about patients who had typhoid
• The Conversation. Decades neglecting an ancient disease has triggered
a health emergency around the world. https://theconversa-
tion.com/decades-neglecting-an-ancient-disease-has-triggered-a-
health-emergency-around-the-world-121282
‐ History of typhoid fever including the spread by asymptomatic
carriers and administration of the typhoid vaccine in willing military
personnel as early as 1898. Free
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